- Home
- TXG vs HROW Comparison
TXG vs HROW Comparison
Compare TXG & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- HROW
- Stock Information
- Founded
- TXG 2012
- HROW 1998
- Country
- TXG United States
- HROW United States
- Employees
- TXG N/A
- HROW N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- TXG Industrials
- HROW Health Care
- Exchange
- TXG Nasdaq
- HROW Nasdaq
- Market Cap
- TXG 1.6B
- HROW 1.4B
- IPO Year
- TXG 2019
- HROW N/A
- Fundamental
- Price
- TXG $12.86
- HROW $43.15
- Analyst Decision
- TXG Buy
- HROW Strong Buy
- Analyst Count
- TXG 12
- HROW 7
- Target Price
- TXG $13.54
- HROW $64.67
- AVG Volume (30 Days)
- TXG 2.2M
- HROW 506.9K
- Earning Date
- TXG 10-28-2025
- HROW 11-12-2025
- Dividend Yield
- TXG N/A
- HROW N/A
- EPS Growth
- TXG N/A
- HROW N/A
- EPS
- TXG N/A
- HROW N/A
- Revenue
- TXG $644,466,000.00
- HROW $227,661,000.00
- Revenue This Year
- TXG $2.15
- HROW $45.86
- Revenue Next Year
- TXG N/A
- HROW $41.41
- P/E Ratio
- TXG N/A
- HROW N/A
- Revenue Growth
- TXG 2.02
- HROW 47.69
- 52 Week Low
- TXG $6.78
- HROW $20.85
- 52 Week High
- TXG $24.38
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- TXG 45.60
- HROW 69.90
- Support Level
- TXG $12.39
- HROW $38.47
- Resistance Level
- TXG $13.39
- HROW $44.07
- Average True Range (ATR)
- TXG 0.61
- HROW 1.71
- MACD
- TXG -0.12
- HROW 0.38
- Stochastic Oscillator
- TXG 21.74
- HROW 89.11
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.